200 related articles for article (PubMed ID: 21318590)
21. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
25. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
26. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
27. Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia.
Tseng DS; Li D; Cholleti SM; Wei JC; Jodesty Y; Pham HV
Perm J; 2019; 23():. PubMed ID: 30939286
[TBL] [Abstract][Full Text] [Related]
28. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
29. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score.
Patil T; Murphy K; Woodard L; Lebrecht M
Pharmacotherapy; 2020 Dec; 40(12):1219-1227. PubMed ID: 33073362
[TBL] [Abstract][Full Text] [Related]
30. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.
Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
Surg Obes Relat Dis; 2017 Jun; 13(6):951-959. PubMed ID: 28223087
[TBL] [Abstract][Full Text] [Related]
31. Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.
He W; Shu X; Zhu E; Deng B; Lin Y; Wu X; Zhou Z; Wang J; Nie R
BMC Cardiovasc Disord; 2021 Feb; 21(1):75. PubMed ID: 33546595
[TBL] [Abstract][Full Text] [Related]
32. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
33. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
34. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
35. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
[TBL] [Abstract][Full Text] [Related]
36. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
[TBL] [Abstract][Full Text] [Related]
37. Effect of long-term proton pump inhibitor therapy on complete blood count parameters and selected trace elements: a pilot study.
Kaczmarczyk O; Przybylska-Feluś M; Piątek-Guziewicz A; Wcisło K; Krośniak M; Kryczyk-Kozioł J; Kleszcz K; Zagrodzki P; Cibor D; Mach T; Zwolińska-Wcisło M
Pol Arch Intern Med; 2020 Mar; 130(3):179-186. PubMed ID: 31825323
[TBL] [Abstract][Full Text] [Related]
38. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
40. Association of Proton Pump Inhibitor Use With Serum Biomarkers of Inflammation, Insulin Resistance, Cardiovascular Risk, and Renal Function.
Austin GL; Weiskopf JR; Czwornog JL
J Clin Gastroenterol; 2018 Sep; 52(8):691-695. PubMed ID: 29099466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
